The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

the Federal Trade Commission alleged in a lawsuit filed Friday. PBMs run prescription drug coverage for insurers, large ...

The Dodge County Sheriff’s Office sent an undercover law enforcement officer, posing as the victim, to complete the transfer ...

The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...

And lest the wanna-be bullies of public relations (like those called out in a 2021 Mother Jones’ barnburner Amazon exposé) ...

LinkedIn suspends AI training with UK user data after ICO intervention. Tech giants face scrutiny over data privacy in AI ...

When you’re hunting for work, a text alerting you to a new listing that sounds like your dream job could be your big break.

A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...

U.S. Federal Trade Commission Chair Lina Khan on Friday welcomed that companies are weighing antitrust considerations early ...

The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...

The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...